{
  "url": "https://openlegislation.uk/eu-regulation-2010-1235/article-2",
  "json_url": "https://openlegislation.uk/eu-regulation-2010-1235/article-2.json",
  "legislation": "eur/2010/1235",
  "legislation_title": "Regulation (EU) No 1235/2010 of the European Parliament and of the Council of 15 December 2010 amending, as regards pharmacovigilance of medicinal products for human use, Regulation (EC) No 726/2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency, and Regulation (EC) No 1394/2007 on advanced therapy medicinal products (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-regulation-2010-1235",
  "path": "article/2",
  "kind": "article",
  "number": "2",
  "heading": "Amendments to Regulation (EC) No 1394/2007",
  "text": "Article 20(3) of Regulation (EC) No 1394/2007 is replaced by the following:\n‘3. The Executive Director of the Agency shall ensure appropriate coordination between the Committee for Advanced Therapies and the other Committees of the Agency, in particular the Committee for Medicinal Products for Human Use, the Pharmacovigilance Risk Assessment Committee and the Committee for Orphan Medicinal Products, their working parties and any other scientific advisory groups.’.",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eur/2010/1235/article/2",
    "retrieved_at": "2026-11-01T14:50:25.100090+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}